NEW YORK, Dec. 22 /PRNewswire-FirstCall/ -- Delcath Systems, Inc. , a medical technology company testing its proprietary treatment method for primary and metastatic cancers to the liver, announced today that Professor Riccardo Lencioni has joined the Company's Scientific Advisory Board, effective immediately.
Professor Lencioni is an Associate Professor of Radiology at the University of Pisa in Italy and the Director of the Division of Diagnostic Imaging and Intervention at Pisa University Hospital. He is Chairman of the Membership Committee of the Cardiovascular and Interventional Radiological Society of Europe, and Chairman of the Programme Committee of the European Conference on Interventional Oncology. He is also a member of the Steering Committee of the World Conference on Interventional Oncology, and was a founder of the International Liver Cancer Association, in which he also acts as a member of the Governing Board. Professor Lencioni has been a Visiting Professor at 20 different European, American and Asian universities.
Professor Lencioni has edited seven books and has authored 135 articles in peer-reviewed international journals and 40 book chapters in textbooks of Radiology, Gastroenterology and Surgery. He has been an invited or honorary lecturer for more than 400 international meetings and conferences.
About Delcath Systems, Inc.
Delcath Systems Inc. is a medical device company specializing in cancer treatment. The Company is testing a proprietary, patented drug delivery system for the treatment of liver cancers. Delcath's novel drug delivery platform is testing the delivery of ultra-high doses of anti-cancer drugs to the liver while preventing these high doses of drug from entering the patient's bloodstream. The Company maintains a broad intellectual property portfolio on a worldwide basis including the U.S., Europe, Asia and Canada. For more information, please visit the Company's website at www.delcath.com.
CONTACT: Investors, Doug Sherk or Stacey Fisher, +1-415-896-6820, or
Media, Steve DiMattia, +1-646-201-5445, all of EVC Group, for Delcath
Systems, Inc.
Web site: http://www.delcath.com/
